Syndax Pharmaceuticals (NASDAQ:SNDX) just reported results for the first quarter of 2024.
- Syndax Pharmaceuticals reported earnings per share of -85 cents. This was above the analyst estimate for EPS of -98 cents.
- The company did not report any revenue for the quarter.